- Previous Close
0.9563 - Open
0.9700 - Bid 0.8900 x 900
- Ask 0.9000 x 4000
- Day's Range
0.8566 - 0.9250 - 52 Week Range
0.5400 - 1.3900 - Volume
38,389 - Avg. Volume
101,963 - Market Cap (intraday)
69.9M - Beta (5Y Monthly) 1.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.12
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
www.milestonescientific.comRecent News: MLSS
View More
Performance Overview: MLSS
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MLSS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MLSS
View MoreValuation Measures
Market Cap
74.49M
Enterprise Value
70.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.47
Price/Book (mrq)
10.31
Enterprise Value/Revenue
7.89
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-52.01%
Return on Assets (ttm)
-38.46%
Return on Equity (ttm)
-65.21%
Revenue (ttm)
8.88M
Net Income Avi to Common (ttm)
-4.62M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
4.78M
Total Debt/Equity (mrq)
4.32%
Levered Free Cash Flow (ttm)
-2.85M